Walgreens offloads stake in infusion company for $330M

Walgreens jettisoned its remaining stake in infusion company Option Care Health for $330 million as it concentrates on its pharmacy and primary care businesses.

Advertisement

The company sold 10.8 million shares of common stock of Option on June 8. Walgreens has been focusing on retail healthcare with its majority stake in primary care chain VillageMD.

Walgreens said it intends to use the proceeds to pay down debt, fund its strategic priorities and further its “transformation to a consumer-centric healthcare company.” The company previously unloaded 15.5 million shares of Option in March.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.